SeaCrest Wealth Management LLC Has $1.04 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SeaCrest Wealth Management LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 1,982 shares of the medical equipment provider’s stock after purchasing an additional 42 shares during the period. SeaCrest Wealth Management LLC’s holdings in Intuitive Surgical were worth $1,035,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in ISRG. Massachusetts Financial Services Co. MA acquired a new position in shares of Intuitive Surgical during the third quarter valued at about $558,807,000. International Assets Investment Management LLC raised its position in Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after purchasing an additional 1,088,415 shares in the last quarter. FMR LLC raised its position in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Wilmington Savings Fund Society FSB raised its position in Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares in the last quarter. Finally, State Street Corp raised its position in Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 48,190 shares of company stock valued at $25,012,927. 0.90% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on ISRG. Leerink Partners increased their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. Mizuho increased their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Price Performance

ISRG opened at $580.11 on Thursday. Intuitive Surgical, Inc. has a one year low of $355.17 and a one year high of $584.60. The company’s 50 day simple moving average is $537.05 and its 200-day simple moving average is $496.50. The stock has a market capitalization of $206.62 billion, a P/E ratio of 93.27, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.